Raffles Medical Group Ltd
RAFLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,699,276 | $1,888,551 | $2,117,149 | $2,367,372 |
| - Cash | $343,671 | $343,598 | $253,127 | $264,988 |
| + Debt | $88,168 | $124,696 | $96,143 | $198,132 |
| Enterprise Value | $1,443,773 | $1,669,649 | $1,960,165 | $2,300,516 |
| Revenue | $751,564 | $708,032 | $822,916 | $723,791 |
| % Growth | 6.1% | -14% | 13.7% | – |
| Gross Profit | $486,138 | $315,935 | $639,981 | $580,521 |
| % Margin | 64.7% | 44.6% | 77.8% | 80.2% |
| EBITDA | $135,829 | $132,890 | $235,870 | $161,266 |
| % Margin | 18.1% | 18.8% | 28.7% | 22.3% |
| Net Income | $62,243 | $90,150 | $143,214 | $84,171 |
| % Margin | 8.3% | 12.7% | 17.4% | 11.6% |
| EPS Diluted | 0.033 | 0.048 | 0.077 | 0.045 |
| % Growth | -30.7% | -37.3% | 71.3% | – |
| Operating Cash Flow | $86,254 | $189,312 | $196,225 | $160,112 |
| Capital Expenditures | -$20,909 | -$20,525 | -$25,299 | -$52,869 |
| Free Cash Flow | $65,345 | $168,787 | $170,926 | $107,243 |